GRACE SIERRA: Open Payments
NPI 1285386151 · MIRAMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 23 payments from 8 companies in 2025. Trend: 2023 $267 · 2024 $294 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $166 |
| Daiichi Sankyo Inc. | 5 | $130 |
| Stemline Therapeutics Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Lilly USA, LLC | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $26 |
| Caris MPI, Inc. | 1 | $20 |
Products named: Enhertu, KEYTRUDA, Orserdu, VERZENIO, KISQALI, LYNPARZA, MI CANCER SEEK.
Industry payments across FL — which companies pay providers there.
